1. A Pharmacist's Guide to PCSK9 Inhibitors:

2. Program Goals

3. Statistics

4. Hospital Discharges for Patients With CVD

5. Need for Care

6. Statins and Patient Groups

7. Diagnosing Statin Intolerance

8. Clinical Factors That Increase the Risk of Statin Intolerance

9. ACC Statin Intolerance App

10. Inadequate Statin Response

11. New Drug Class: PCSK9 Inhibitors

12. Bococizumab

13. Guidance for Use of PCSK9 Inhibitors

14. Familial Hypercholesterolemia (FH)

16. Pharmacoeconomic Implications

17. Cost Effectiveness Study

18. Cost Effectiveness – Future Considerations